Katherine Holtby, | |
540 White Spruce Blvd, Rochester, NY 14623-1613 | |
(585) 851-8259 | |
(585) 310-2761 |
Full Name | Katherine Holtby |
---|---|
Gender | Female |
Speciality | Physical Therapy |
Experience | 7 Years |
Location | 540 White Spruce Blvd, Rochester, New York |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1235655366 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | 41998 (New York) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Thrive Physical Therapy Pllc | 7719229285 | 2 |
News Archive
Pinpointing the exact genetic cause of inherited deafness has always involved sequencing one gene at a time, a process that can take up to a year and cost roughly $1,000 per gene. It would cost around $75,000 to test all known deafness causing genes using this approach. Now University of Iowa researchers working with colleagues at Baylor College of Medicine have developed a test that can screen all of the genes known to cause deafness in a single run, in one to three months and for about $2,000.
In a post in Management Sciences for Health's (MSH) "Global Health Impact" blog, Jonathan Quick, president and CEO of MSH, interviews Sylvia Vriesendorp, technical lead on leadership at MSH, about Kenya's First National Conference on Health Leadership, Management and Governance, which took place in February and "demonstrated the long-term vision of the Kenyans who are running the health system."
Drinking caffeinated coffee appears to have both beneficial and harmful short-term health effects: increased abnormal heartbeats, increased physical activity and reduced sleep duration, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2021.
Progenics Pharmaceuticals, Inc. today announced the completion of the treatment phase of a 1,034-patient, one-year, open-label, international, phase 3 safety study of methylnaltrexone bromide subcutaneous injection in chronic, non-malignant pain patients with opioid-induced constipation (OIC).
Loyola University Chicago researchers are taking advantage of a quirk in the evolution of fruit fly genes to help develop new weapons against cancer.
› Verified 4 days ago
Provider Name | Thrive Physical Therapy Pllc |
---|---|
Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
Provider Identifiers | NPI Number: 1215494604 PECOS PAC ID: 7719229285 Enrollment ID: O20190502001266 |
News Archive
Pinpointing the exact genetic cause of inherited deafness has always involved sequencing one gene at a time, a process that can take up to a year and cost roughly $1,000 per gene. It would cost around $75,000 to test all known deafness causing genes using this approach. Now University of Iowa researchers working with colleagues at Baylor College of Medicine have developed a test that can screen all of the genes known to cause deafness in a single run, in one to three months and for about $2,000.
In a post in Management Sciences for Health's (MSH) "Global Health Impact" blog, Jonathan Quick, president and CEO of MSH, interviews Sylvia Vriesendorp, technical lead on leadership at MSH, about Kenya's First National Conference on Health Leadership, Management and Governance, which took place in February and "demonstrated the long-term vision of the Kenyans who are running the health system."
Drinking caffeinated coffee appears to have both beneficial and harmful short-term health effects: increased abnormal heartbeats, increased physical activity and reduced sleep duration, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2021.
Progenics Pharmaceuticals, Inc. today announced the completion of the treatment phase of a 1,034-patient, one-year, open-label, international, phase 3 safety study of methylnaltrexone bromide subcutaneous injection in chronic, non-malignant pain patients with opioid-induced constipation (OIC).
Loyola University Chicago researchers are taking advantage of a quirk in the evolution of fruit fly genes to help develop new weapons against cancer.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Katherine Holtby, 92 West Ave, Brockport, NY 14420-1306 Ph: (585) 637-0790 | Katherine Holtby, 540 White Spruce Blvd, Rochester, NY 14623-1613 Ph: (585) 851-8259 |
News Archive
Pinpointing the exact genetic cause of inherited deafness has always involved sequencing one gene at a time, a process that can take up to a year and cost roughly $1,000 per gene. It would cost around $75,000 to test all known deafness causing genes using this approach. Now University of Iowa researchers working with colleagues at Baylor College of Medicine have developed a test that can screen all of the genes known to cause deafness in a single run, in one to three months and for about $2,000.
In a post in Management Sciences for Health's (MSH) "Global Health Impact" blog, Jonathan Quick, president and CEO of MSH, interviews Sylvia Vriesendorp, technical lead on leadership at MSH, about Kenya's First National Conference on Health Leadership, Management and Governance, which took place in February and "demonstrated the long-term vision of the Kenyans who are running the health system."
Drinking caffeinated coffee appears to have both beneficial and harmful short-term health effects: increased abnormal heartbeats, increased physical activity and reduced sleep duration, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2021.
Progenics Pharmaceuticals, Inc. today announced the completion of the treatment phase of a 1,034-patient, one-year, open-label, international, phase 3 safety study of methylnaltrexone bromide subcutaneous injection in chronic, non-malignant pain patients with opioid-induced constipation (OIC).
Loyola University Chicago researchers are taking advantage of a quirk in the evolution of fruit fly genes to help develop new weapons against cancer.
› Verified 4 days ago
Carrie Marie Nicholas, Physical Therapist Medicare: Medicare Enrolled Practice Location: 3399 Winton Rd S, Rochester, NY 14623 Phone: 585-334-6000 | |
Hannah Steiner Becker, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Elmwood Ave, Suite 100, Rochester, NY 14620 Phone: 585-271-0761 | |
Jacob Resnick, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 515 Long Pond Rd, Rochester, NY 14612 Phone: 585-227-2310 Fax: 585-227-2312 | |
Laura Jean Mcgowan, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 620 Westfall Rd, Rochester, NY 14620 Phone: 585-461-8500 | |
Shelby Hutton, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Elmwood Ave Ste 400, Rochester, NY 14620 Phone: 585-271-0680 | |
Lattimore Physical Therapy Physical Therapist Medicare: Medicare Enrolled Practice Location: 383 White Spruce Blvd, Rochester, NY 14623 Phone: 585-442-6067 Fax: 585-442-6073 | |
Mrs. Shannon N Schiller, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 120 Erie Canal Dr, Suite 310, Rochester, NY 14626 Phone: 585-225-6296 Fax: 585-225-2839 |